Overview

• About 300,000 additional severely immunosuppressed people aged 18 to 49 become eligible from 1 September in England.
• GP surgeries will contact patients to invite them for vaccination, and eligible people can also book directly with their practice.
• Newly eligible groups include people with leukaemia or lymphoma and those undergoing chemotherapy.
• Shingrix is given in two doses with the second 8 weeks to 6 months after the first, and it can be administered alongside flu and COVID‑19 vaccines.
• Health officials say the vaccine is safe and effective and reduces severe illness, with earlier programme years estimated to have prevented thousands of shingles and post‑herpetic neuralgia cases.